Dr. Metjian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1665 Aurora Ct
Aurora, CO 80045Phone+1 720-848-0000Fax+1 720-848-1786
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2005 - 2007
- University of North Carolina HospitalsResidency, Internal Medicine, 2001 - 2004
- Drexel University College of MedicineClass of 2001
Certifications & Licensure
- CO State Medical License 2020 - 2025
- NC State Medical License 2001 - 2024
- PA State Medical License 2005 - 2010
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 16 citationsRace, rituximab, and relapse in TTP.Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian
Blood. 2022-09-22 - 59 citationsAgonists Cause Nuclear Translocation of Phosphatidylinositol 3-Kinase γ A Gβγ-DEPENDENT PATHWAY THAT REQUIRES THE p110γ AMINO TERMINUSAra Metjian, Richard L. Roll, Alice D. Ma, Charles S. Abrams
The Journal of Biological Chemistry. 1999-09-24 - 521 citationsCaplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.Marie Scully, Spero R. Cataland, Flora Peyvandi, Paul Coppo, Paul Knöbl
The New England Journal of Medicine. 2019-01-09
Abstracts/Posters
- Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression RegimenAra Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease SeverityAra Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsAra Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: